Leave a comment

SureX® HPV 25X Genotyping Kit (F488) at American Association for Clinical Chemistry

As per Health Gene Technologies annual tradition, we took part in the 70th Annual Scientific Meeting of American Association for Clinical Chemistry (AACC). As per its own annual tradition AACC presented the attendees with a variety of innovative scientific solutions for the clinical space, with an estimated number of 20’000 persons having attended.

AACC 2018 4

Health Gene Technologies has made steep advances in the medical diagnostic product development field in the past few years, undergoing hundreds of clinical tests for our products, successfully obtaining the CFDA registration. This year, we have focused on presenting our best-performing human papillomavirus assay, which focuses on the genotyping of 25 targets on the E6 and E7 genes. With double controls for both the PCR and CE workflows, it is one of the most attractive products on the market right now.

World-wide epidemiological studies have shown that cervical cancer is the second most common malignant disease in women. High-risk oncogenic HPV (Human papillomavirus) types (including HPV 16 and HPV 18) are associated with 99.7% of all cervical cancers, indicating that the presence of HPV is an obligatory element in the development of cervical cancer. Persistent infection with high-risk HPV types may progress to precancerous lesions, which is the root cause of nearly all cases of cervical cancer. HGT’s SureX® HPV 25X Genotyping Kit can detect and genotype 25 HPV types simultaneously.

AACC 2018 1



Leave a comment

Health Gene Technologies partner company Biosan participates in NEXTlab, Poland

From 6th to 8th of June, Health Gene Technologies’s partner in the regions of Latvia and Poland, Biosan, has participated in the international scientific conference NEXTlab Next Generation of Forensic Biology Laboratory, which took place in Gdynia, Poland.

The conference was addressed to researchers working on the subject of forensic genetic analyses, DNA databases, law and related fields. The presentations were given by researchers from Polish and foreign scientific institutes, universities and forensic laboratories of the Police and they covered the following subjects:

  • Prediction analysis and determination of phenotype characteristics basing upon DNA analysis;
  • Forensic DNA analysis of plants, animals and microbes;
  • Automation of laboratory processes and mobile solutions dedicated to forensic biology;
  • Legal and ethical aspects of genetic examination;
  • Modern technology for detection and recovery of biological evidence;
  • Application of statistical methods in forensic DNA analysis;
  • Bloodstain Pattern Analysis;
  • Education and training for forensic experts.

The conference was an excellent opportunity to present the newest products, services and technologies to a wide range of forensic geneticists representing national and foreign forensic medicine institutes, medical universities and forensic laboratories.

Among others, Biosan was proud to present the products of Health Gene Technologies Co., Ltd. Biosan Product manager and Head of Molecular Diagnostic division Mr. Andrejs Gaivoronskis (M.Sc. Biol) participated with dedicated presentation about possibilities and advantages of using SureID® 21G Human STR Identification Kit.


The company Biosan was founded by Vasily Bankovsky (Ph.D., Molecular Biology) and Svetlana Bankovska (MSc., Biochemistry) from the Institute of Microbiology in the Latvian Republic Academy of Science.

Biosan’s philosophy is to develop modern exciting personal products for sample preparation in the field of genomics, proteomics and cellomics. The latest trends are the result of diagnostics technology shifting on a level of detection of bio-polymorphism of genetic, metabolitic and cell diseases. Innovation, design and focus on the individual consumer proved to be in demand in the world biotechnological market and during recent years our Personal Laboratory products have become well-known all over the world under different leading brands.

Keywords: Biosan, Health Gene Technologies, Forensic, HGT, SureID, STR, Genetics, Biology, Conference, Poland, Gdynia.

For purchasing Health Gene Technologies’ products in the area of Poland and Latvia, please contact Mr. Andrejs Gaivoronskis:,

Leave a comment

HEALTH Gene Technologies presents new products at Bundelkhand University in Jhansi, India

HEALTH Gene Technologies took part in an international conference on Advances in Forensic DNA technology organized by Institute of Forensic Science and Criminology at Bundelkhand University in the city of Jhansi on February 22-24.

The conference was a push for connecting academics, students, the police and new technology developers to have a joint conversation about the present state and the future advances of forensic DNA technologies in the country. As cities in India are building a number of new forensic DNA laboratories in response to rising crime rates, there is a pressing need to share experience among laboratory experts.

The presentations in the conference were primarily focused on STR forensic analysis, many sharing case experiences of sexual assault, murder, kidnapping and paternity disputes.

HEALTH Gene Technologies took the opportunity to introduce a new kit of SureID® 23comp Human DNA Identification Kit for complex kinship and paternity cases.

Forensic State Laboratory in Sagar, Madhya Pradesh State, presented own experience of working with the kit in a speech titled “Use of Alternative STR Markers in Forensic DNA Typing”. The presentation focused on three complex paternity cases that would have been difficult to solve without complementary loci kits.

For more information about HEALTH Gene Technologies’ SureID® 23comp Human DNA Identification Kit, press here :

Leave a comment

Health Gene Tech showcases new products at ISFG


ISFG – the International Society of Forensic Genetics – has held its 27th Congress in Seoul, South Korea, from August 28 to September 2. The congress united scientists, industry innovators and public security actors to discuss new technologies and advances in forensic science. This year’s conference focused on seven main topics:

  1. Massively Parallel Sequencing;
  2. Population Genetics, Lineage, Ancestry, Paternity;
  3. Non-human DNA, microbiology and other MPS;
  4. Body Fluid, Touch DNA, Forensic Biology;
  5. Predictive, Biostatistics;
  6. Ethics & Legal, DNA databases, DVI;
  7. New Technologies, DNA Methods, QC.


Scientific partner of Health Gene Technologies – the University of Technology Sydney and Beijing Institute of Genomics Chinese Academy of Science- presented a poster of our newest scientific collaboration with the SureID Compass kit that simultaneously detects 16 autosome STR loci and 17 Y-STR loci, and is suitable for building autosome STR and Y-STR databases.


Additionally, Health Gene Technologies launched our newest product development for complex kinship testing – 23Comp. This set of non-CODIS loci provides a CPI of 1-3.0483×10E-26. It can be used as a complementary STR kit to popular commercial STR kits when complex cases need to be solved. Free product trials of 23Comp are available upon request at

We will meet again at ISFG’s 28th Congress in Prague in 2019!

Leave a comment

Health Gene Technologies attends 69th AACC in San Diego

This year’s AACC was one of the biggest exhibitions and conferences in the history of American Association of Clinical Chemistry.

The 69th AACC Clinical Lab Expo featured 789 exhibitors and covered 246,000 net square feet, also making this the largest show floor in AACC’s history. As of Wednesday, August 2, more than 21,300 laboratory medicine professionals and healthcare leaders had registered for the meeting, which is a 7.9% increase over meeting attendance in 2016 and the highest number of attendees that have come to the meeting in its history.

Health Gene Technologies took part in the event fourth year in a row. This exhibition focused on demonstrating the mature product of clinical diagnostics, the star of the forensic science, and the RUO products in HGT pipeline.

Respiratory pathogen infection is one of the most common clinical diseases, causing millions of mortality worldwide every year. In the global appeal to reduce the abuse of antibiotics, a clear identification of respiratory infection pathogens and then targeted treatment help to alleviate the serious problem of antibiotic abuse. Health Gene Technologies’SureX® 13 Respiratory Pathogen Multiplex Kit ​covering 11 common respiratory viruses, chlamydia and Mycoplasma pneumoniae. Compared to other products on the market, this kit has advantagesof being comprehensive, multiplex in one tube, triple quality controls, and accurate results.

World-wide epidemiological studies have shown that cervical cancer is the second most common malignant disease in women. High-risk oncogenic HPV (Human papillomavirus) types (including HPV 16 and HPV 18) are associated with 99.7% of all cervical cancers, indicating that the presence of HPV is an obligatory element in the development of cervical cancer. Persistent infection with high-risk HPV types may progress to precancerous lesions, which is the root cause of nearly all cases of cervical cancer. HGT’s SureX® HPV 25X Genotyping Kit can detect and genotype25 HPV typessimultaneously.

During the three-day exhibition, HGT attracted many visitors discussing the possible directions of follow-up work.


HGT is committed to developing and manufacturing simple, rapid and effective nucleic acid (DNA) testing solutions for molecular diagnostics, clinical research and forensic analysis.

Leave a comment

Health Gene Technologies to take part in AACC 2017, San Diego

Health Gene Technologies has taking part in the American Association for Clinical Chemistry the fourth time this year, see our previous stories 2014 2015 2016.

2017 AACC

The vision of AACC has united medical healthcare professionals over many years: “AACC is a global scientific and medical professional organization dedicated to clinical laboratory science and its application to healthcare. Our leadership in education, advocacy and collaboration helps lab professionals adapt to change and do what they do best: provide vital insight and guidance so patients get the care they need.”

This year Health Gene Technologies will be presenting our new 13 Respiratory Pathogen Multiplex Kit:


  • Multiplex: Adaptable to detection of multiple pathogens simultaneously.
  • Single-tube: Perform cDNA synthesis and multiplex PCR in one tube.
  • Comprehensive: Identify 11 most common respiratory viruses, chlamydia and Mycoplasma pneumonia.
  • Sensitive: High sensitivity similar to qPCR.
  • Efficient: Perform the whole assay within 4 hrs; Hands-on time as short as 0.5 hr; Up to 192 samples within 8 hrs
  • Accurate:
  1.  Three controls monitor sample quality and the whole assay, reducing risk of false negatives
  2.  No cross-reaction with other pathogens
  3.  Efficient anti-contamination system, reducing risk of false positives
  • Objective: Normalize signaling on CE platforms by standard mix; Results output by software.
  • Compatible: Work well on oropharyngeal swabs and sputum; Perform PCR on common thermal cyclers and

CE platforms (GeXP/CEQ or ABI3130/3500).

  • Economic: Much cheaper than qPCR (for 13 pathogens detection) and liquid chip tests.

 呼吸道 英

Health Gene Technologies is looking forward to welcoming you in our booth #3857!